MedPath

In-Use Test With a Cosmetic Product

Not Applicable
Completed
Conditions
Dermatitis, Atopic
Interventions
Other: WO 4260 Cosmetic Product for Topical Use
Registration Number
NCT03252730
Lead Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Brief Summary

The aim of the study is to evaluate the tolerance of the product WO 4260 by a dermatologist. Additional objectives of this clinical in-use study are to evaluate the cosmetic features and acceptance of the product by means of a questionnaire in an interview situation and by skin hydration measurements on the scalp.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • age: ≥ 18 years
  • sex: approx. 50% male and approx. 50% female
  • users of hair tonic for dry scalp
  • dry, itchy scalp prone to atopic eczema / atopic dermatitis
Exclusion Criteria
  • any deviation from the above-mentioned criteria
  • users of sour hair rinse
  • subjects who wash their hair more than once a day
  • other dermatological disorders (scars, moles) on the scalp
  • known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
  • topical medication in the test area within 1 month prior to study start
  • systemic medication with anti-inflammatory agents and antibiotics within 2 weeks prior to starting of the study
  • systemic medication with retinoids, antihistamines and/or immunomodulators (e.g. cortisone, corticosterone, chemotherapeutic agents) within 4 weeks prior to starting of the study
  • systemic illness of the subject at the beginning of the study
  • pregnancy and period of breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
WO 4260 Cosmetic Product for Topical UseWO 4260 Cosmetic Product for Topical UseWO 4260 is used to treat dry and itchy scalp
Primary Outcome Measures
NameTimeMethod
Tolerance of the Test Product on the Scalpafter 4 weeks of treatment

Change from Baseline Tolerance on the Scalp at 4 weeks

Secondary Outcome Measures
NameTimeMethod
Skin Hydration of the Scalpbefore product treatment; after 2 and 4 weeks of treatment

The measurement is performed using the DermaLab® device with the moisture pin (Cortex Technology)

Performance of the Test Productafter 4 weeks of treatment

Subjective assessment of product performance in a questionnaire-based interview

Tolerance of the Test Product on the Scalpafter 2 weeks of treatment

Dermatological assessment of the Scalp concerning the Tolerance of the Test Product regarding erythema, edema dryness etc. Each item is scored 0=absent to 4=extreme.

Trial Locations

Locations (1)

SIT Skin Investigation and Technology Hamburg GmbH

🇩🇪

Hamburg, Germany

SIT Skin Investigation and Technology Hamburg GmbH
🇩🇪Hamburg, Germany
© Copyright 2025. All Rights Reserved by MedPath